{{translating|[[:en:Adenosine_reuptake_inhibitor|:en:Adenosine reuptake inhibitor]]||tpercent=|time=2020-11-01UTC10:01:36}}
{{Request translation|en|}}
[[Image:Adenosin.svg|thumb]]]]

'''腺苷再攝取抑制劑'''（Adenosine reuptake inhibitor，縮寫為AdoRI）是一類藥物，它通過阻斷一個或多個平衡核苷轉運蛋白（ENTs）的作用，作為[[嘌呤|嘌呤]][[核苷|核苷]]和[[神經遞質|神經遞質]][[腺苷|腺苷]]的[[再攝取抑制劑|再攝取抑制劑]]。<ref name="pmid15037197">{{cite journal |vauthors=SenGupta DJ, Unadkat JD | title = Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep | journal = Biochem Pharmacol | volume = 67 | issue = 3 | pages = 453–458 | year = 2004 | pmid = 15037197 | doi = 10.1016/j.bcp.2003.09.018 }}</ref><ref name="pmid14759222">{{cite journal |vauthors=Endres CJ, Sengupta DJ, Unadkat JD | title = Mutation of leucine-92 selectively reduces the apparent affinity of inosine, guanosine, NBMPR [S6-(4-nitrobenzyl)-mercaptopurine riboside] and dilazep for the human equilibrative nucleoside transporter, hENT1 | journal = Biochem J | volume = 380 | issue = 1 | pages = 131–137 | year = 2004 | pmid = 14759222 | doi = 10.1042/BJ20031880 | pmc = 1224139 }}</ref><ref name="pmid15131243">{{cite journal |vauthors=Chaudary N, Naydenova Z, Shuralyova I, Coe IR | title = The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line, HL-1 |url=https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2004-09_310_3/page/1190 | journal = J Pharmacol Exp Ther | volume = 310 | issue = 3 | pages = 1190–1198 | year = 2004 | pmid = 15131243 | doi = 10.1124/jpet.104.067157 }}</ref>這繼而導致腺苷的細胞外濃度增加，因此[[腺苷能|腺苷能]][[神經傳遞|神經傳遞]]增加。

== 參考資料 ==
{{Reflist|35em}}

{{Adenosinergics}}
{{Neuromodulation}}

[[Category:作用於神經系統的藥物|Category:作用於神經系統的藥物]]